Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 12,642 | 11,288 | 22,921 | 30,949 | 28,359 |
| Operating Income | -12,642 | -11,288 | -22,921 | -30,949 | -28,359 |
| Interest Expense | 0 | 0 | 0 | 0 | 2,432 |
| Other Income | 148 | 504 | 463 | 2,958 | 577 |
| Pre-tax Income | -12,494 | -10,785 | -22,458 | -27,991 | -30,213 |
| Net Income Continuous | -12,494 | -10,785 | -22,458 | -27,991 | -30,213 |
| Net Income | $-12,494 | $-10,785 | $-22,458 | $-27,991 | $-30,213 |
| EPS Basic Total Ops | -2.93 | -2.86 | -6.54 | -8.30 | -11.60 |
| EPS Basic Continuous Ops | -2.93 | -2.86 | -6.54 | -8.31 | -11.61 |
| EPS Diluted Total Ops | -2.93 | -2.86 | -6.54 | -8.30 | -11.60 |
| EPS Diluted Continuous Ops | -2.93 | -2.86 | -6.54 | -8.31 | -11.61 |
| EPS Diluted Before Non-Recurring Items | -2.93 | -2.86 | -6.50 | -8.30 | -11.60 |
| EBITDA(a) | $-12,460 | $-11,073 | $-22,717 | $-30,828 | $-28,281 |